Join Biocytogen at CBA Annual Conference
Biocytogen is excited to announce our attendance at the CBA Annual Conference on September 28, 2024, in Foster City! As leaders in antibody discovery and gene-editing technologies, we look forward to connecting with scientists, industry experts, and innovators at this exciting event. Join us at the Crowne Plaza Hotel from 8:00 AM to 5:30 PM to discuss the latest advancements and explore collaborative opportunities!
What is the CBA?
The Chinese Bioscience Association (CBA), founded in 1997 in the San Francisco Bay Area, is a non-profit organization focused on promoting education, networking, and community among life science professionals. Through its numerous conferences and workshops, CBA highlights emerging biotech trends and technologies, attracting a wide range of participants including entrepreneurs, executives, scientists, postdocs, and students. With a diverse membership, CBA serves as a bilingual bridge between the US and Asia, maintaining strong ties with Taiwan, China, Hong Kong, and Singapore. The organization is volunteer-run and supported by sponsors, with its annual conferences and summer picnics being particularly popular.
Event Overview
Time: September 28, 2024 (Saturday), 8am – 5:30pm
Location: Crowne Plaza Hotel (Foster City)
The CBA Annual Conference will bring together leading researchers, doctors, and industry professionals to explore groundbreaking topics in healthcare and biotechnology. The event will feature sessions on cancer research, novel advances in healthcare, and emerging therapies, including T-cell studies and mRNA delivery systems. Attendees will benefit from engaging presentations, keynote speeches, and interactive Q&A sessions. The conference will also include networking opportunities, sponsor talks, and a panel discussion, concluding with a lucky draw and a networking happy hour. This comprehensive program aims to foster collaboration and share insights into the latest innovations in the field.
Event Schedule
Time | Activity | Details |
8:00 AM | Registration & Networking | Attendees check-in and network. |
9:00 AM | Introduction | Opening remarks from the event organizers. |
9:30 AM | Morning Session 1: The Fight Against Cancer | Presentations, keynote speeches, and Q&A on cancer research. |
11:00 AM | Morning Session 2: Novel Advances in Healthcare | Focus on AI, disease detection, and drug discovery. |
12:00 PM | Lunch & Networking | Networking opportunities and sponsor talks during lunch. |
1:00 PM | Afternoon Session 1: Rise of Advanced Therapies | Discussing T-cell studies, mRNA delivery systems, and advanced biotech. |
2:30 PM | Afternoon Session 2: How to Create A Success Story | Success stories from industry experts and researchers. |
4:00 PM | Panel Discussion | Experts share insights on future healthcare challenges and innovations. |
5:00 PM | Closing Remarks & Lucky Draw | Closing statements followed by a prize draw. |
5:30 PM – 7:00 PM | Networking Happy Hour | Informal networking session with refreshments. |
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to seeing you at the CBA Annual Conference on September 28, 2024, in Foster City!